- Home
- CARM vs PMAX Comparison
CARM vs PMAX Comparison
Compare CARM & PMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARM
- PMAX
- Stock Information
- Founded
- CARM 2016
- PMAX 2019
- Country
- CARM United States
- PMAX Hong Kong
- Employees
- CARM N/A
- PMAX N/A
- Industry
- CARM Biotechnology: Pharmaceutical Preparations
- PMAX
- Sector
- CARM Health Care
- PMAX
- Exchange
- CARM Nasdaq
- PMAX Nasdaq
- Market Cap
- CARM 8.4M
- PMAX 7.9M
- IPO Year
- CARM N/A
- PMAX 2024
- Fundamental
- Price
- CARM $0.41
- PMAX $0.50
- Analyst Decision
- CARM Hold
- PMAX
- Analyst Count
- CARM 5
- PMAX 0
- Target Price
- CARM $0.90
- PMAX N/A
- AVG Volume (30 Days)
- CARM 42.2M
- PMAX 1.5M
- Earning Date
- CARM 08-07-2025
- PMAX 04-28-2025
- Dividend Yield
- CARM N/A
- PMAX N/A
- EPS Growth
- CARM N/A
- PMAX N/A
- EPS
- CARM N/A
- PMAX N/A
- Revenue
- CARM $19,964,000.00
- PMAX $4,694,079.00
- Revenue This Year
- CARM N/A
- PMAX N/A
- Revenue Next Year
- CARM N/A
- PMAX N/A
- P/E Ratio
- CARM N/A
- PMAX N/A
- Revenue Growth
- CARM 32.45
- PMAX N/A
- 52 Week Low
- CARM $0.14
- PMAX $0.28
- 52 Week High
- CARM $1.42
- PMAX $4.70
- Technical
- Relative Strength Index (RSI)
- CARM 51.65
- PMAX N/A
- Support Level
- CARM $0.37
- PMAX N/A
- Resistance Level
- CARM $0.44
- PMAX N/A
- Average True Range (ATR)
- CARM 0.07
- PMAX 0.00
- MACD
- CARM -0.01
- PMAX 0.00
- Stochastic Oscillator
- CARM 10.37
- PMAX 0.00
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
About PMAX Powell Max Limited Class A Ordinary Shares
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.